246 related articles for article (PubMed ID: 1464457)
1. Characterization of specific binding sites for [3H]-1,3-di-o-tolyl-guanidine (DTG) in the rat glioma cell line C6-BU-1.
Georg A; Friedl A
Glia; 1992; 6(4):258-63. PubMed ID: 1464457
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma x rat glioma hybrid cell line NG108-15.
Georg A; Friedl A
J Pharmacol Exp Ther; 1991 Nov; 259(2):479-83. PubMed ID: 1658298
[TBL] [Abstract][Full Text] [Related]
3. Characterization of specific (+)-[3H]N-allylnormetazocine and [3H]1,3-di(2-tolyl)guanidine binding sites in porcine gastric fundic mucosa.
Harada Y; Hara H; Sukamoto T
J Pharmacol Exp Ther; 1994 Jun; 269(3):905-10. PubMed ID: 8014877
[TBL] [Abstract][Full Text] [Related]
4. Initial identification and characterization of sigma receptors on human peripheral blood leukocytes.
Wolfe SA; Kulsakdinun C; Battaglia G; Jaffe JH; De Souza EB
J Pharmacol Exp Ther; 1988 Dec; 247(3):1114-9. PubMed ID: 2849660
[TBL] [Abstract][Full Text] [Related]
5. Interaction of 1,3-di(2-[5-3H]tolyl) guanidine with sigma 2 binding sites in rat heart membrane preparations.
Dumont M; Lemaire S
Eur J Pharmacol; 1991 Dec; 209(3):245-8. PubMed ID: 1665796
[TBL] [Abstract][Full Text] [Related]
6. Characterization of [3H]desmethylimipramine binding in bovine adrenal medulla: interactions with sigma- and (or) phencyclidine-receptor ligands.
Rogers C; Lemaire S
Can J Physiol Pharmacol; 1992 Nov; 70(11):1508-14. PubMed ID: 1338374
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
Largent BL; Gundlach AL; Snyder SH
J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
[TBL] [Abstract][Full Text] [Related]
8. 1,3-Di(2-[5-3H]tolyl)guanidine labels more than one site in rat forebrain.
Codd EE; Shank RP
Eur J Pharmacol; 1992 Jul; 217(2-3):149-52. PubMed ID: 1425936
[TBL] [Abstract][Full Text] [Related]
9. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
Hellewell SB; Bowen WD
Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717
[TBL] [Abstract][Full Text] [Related]
10. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
[TBL] [Abstract][Full Text] [Related]
11. Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes.
Itzhak Y; Stein I; Zhang SH; Kassim CO; Cristante D
J Pharmacol Exp Ther; 1991 Apr; 257(1):141-8. PubMed ID: 1850463
[TBL] [Abstract][Full Text] [Related]
12. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner BJ; John CS; Bowen WD
Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
[TBL] [Abstract][Full Text] [Related]
13. Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
Kushner L; Zukin SR; Zukin RS
Mol Pharmacol; 1988 Nov; 34(5):689-94. PubMed ID: 2848188
[TBL] [Abstract][Full Text] [Related]
14. Receptors and secretory actions of sigma/phencyclidine agonists in anterior pituitary cells.
Stojilković SS; Dufau ML; Catt KJ
Endocrinology; 1987 Dec; 121(6):2044-54. PubMed ID: 2824179
[TBL] [Abstract][Full Text] [Related]
15. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
Rothman RB; Reid A; Mahboubi A; Kim CH; De Costa BR; Jacobson AE; Rice KC
Mol Pharmacol; 1991 Feb; 39(2):222-32. PubMed ID: 1847495
[TBL] [Abstract][Full Text] [Related]
16. Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via sigma 1 site.
Yamamoto H; Yamamoto T; Sagi N; Klenerová V; Goji K; Kawai N; Baba A; Takamori E; Moroji T
J Neurosci; 1995 Jan; 15(1 Pt 2):731-6. PubMed ID: 7529831
[TBL] [Abstract][Full Text] [Related]
17. [3H]1,3-di(2-tolyl) guanidine binds to a sigma 2 receptor on Jurkat cell membranes, but sigma compounds fail to influence immunomodulatory events in human peripheral blood lymphocytes.
DeHaven-Hudkins DL; Daubert JD; Sawutz DG; Tiberio L; Baine Y
Immunopharmacology; 1996 Oct; 35(1):27-39. PubMed ID: 8913792
[TBL] [Abstract][Full Text] [Related]
18. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex.
Matsuno K; Matsunaga K; Senda T; Mita S
J Pharmacol Exp Ther; 1993 May; 265(2):851-9. PubMed ID: 8496830
[TBL] [Abstract][Full Text] [Related]
19. Acylation of sigma receptors by Metaphit, an isothiocyanate derivative of phencyclidine.
Bluth LS; Rice KC; Jacobson AE; Bowen WD
Eur J Pharmacol; 1989 Feb; 161(2-3):273-7. PubMed ID: 2542047
[TBL] [Abstract][Full Text] [Related]
20. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
Karbon EW; Naper K; Pontecorvo MJ
Eur J Pharmacol; 1991 Jan; 193(1):21-7. PubMed ID: 1675607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
